SNCA: Major genetic modifier of age at onset of Parkinson's disease

ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Movement disorders 2013-08, Vol.28 (9), p.1217-1221
Hauptverfasser: Brockmann, Kathrin, Schulte, Claudia, Hauser, Ann-Kathrin, Lichtner, Peter, Huber, Heiko, Maetzler, Walter, Berg, Daniela, Gasser, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1221
container_issue 9
container_start_page 1217
container_title Movement disorders
container_volume 28
creator Brockmann, Kathrin
Schulte, Claudia
Hauser, Ann-Kathrin
Lichtner, Peter
Huber, Heiko
Maetzler, Walter
Berg, Daniela
Gasser, Thomas
description ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society
doi_str_mv 10.1002/mds.25469
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430396074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3061320421</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</originalsourceid><addsrcrecordid>eNp1kE1LwzAYgIMoOqcH_4AUPKiHar7beBvTTcVN8QOPIW3fSubazKRD9-_tnHoQvCQEnvch74PQHsEnBGN6WhXhhAou1RrqEMFInFKRrKMOTlMRM5KKLbQdwgRjQgSRm2iLMplwlsoO6j-M-72zaGQmzkcvUENj86hyhS0t-MiVkXmByDSRqwM0y_ed8a-2Dq4-DFFhA5gAO2ijNNMAu993Fz0NLh77l_HN7fCq37uJc6aIik0pBJUKJ0BJCoopoIwzoJgWpD0FyAIXlEBJuIEsS4qMc1HKJDO05FmOWRcdrbwz797mEBpd2ZDDdGpqcPOgCWeYKYnb1bro4A86cXNft79rKaoEJoouhccrKvcuBA-lnnlbGb_QBOtlWd2W1V9lW3b_2zjPKih-yZ-ULXC6At7tFBb_m_To_OFHGa8mbGjg43eiDaxlwhKhn8dDfc-FZNfXQg_YJw-mjnE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1429501920</pqid></control><display><type>article</type><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</creator><creatorcontrib>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</creatorcontrib><description>ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.25469</identifier><identifier>PMID: 23674386</identifier><identifier>CODEN: MOVDEA</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Adult ; age at onset ; Age of Onset ; Aged ; alpha-Synuclein - genetics ; Cohort Studies ; Female ; Genetic Association Studies ; genetics ; Humans ; Linear Models ; Male ; Middle Aged ; Movement disorders ; Mutation - genetics ; Parkinson Disease - genetics ; Parkinson Disease - physiopathology ; Parkinson's disease ; Polymorphism, Single Nucleotide - genetics ; SNCA</subject><ispartof>Movement disorders, 2013-08, Vol.28 (9), p.1217-1221</ispartof><rights>Copyright © 2013 Movement Disorder Society</rights><rights>Copyright © 2013 Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</citedby><cites>FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.25469$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.25469$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23674386$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brockmann, Kathrin</creatorcontrib><creatorcontrib>Schulte, Claudia</creatorcontrib><creatorcontrib>Hauser, Ann-Kathrin</creatorcontrib><creatorcontrib>Lichtner, Peter</creatorcontrib><creatorcontrib>Huber, Heiko</creatorcontrib><creatorcontrib>Maetzler, Walter</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><title>Movement disorders</title><addtitle>Mov Disord</addtitle><description>ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</description><subject>Adult</subject><subject>age at onset</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>alpha-Synuclein - genetics</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Genetic Association Studies</subject><subject>genetics</subject><subject>Humans</subject><subject>Linear Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Movement disorders</subject><subject>Mutation - genetics</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson's disease</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>SNCA</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1LwzAYgIMoOqcH_4AUPKiHar7beBvTTcVN8QOPIW3fSubazKRD9-_tnHoQvCQEnvch74PQHsEnBGN6WhXhhAou1RrqEMFInFKRrKMOTlMRM5KKLbQdwgRjQgSRm2iLMplwlsoO6j-M-72zaGQmzkcvUENj86hyhS0t-MiVkXmByDSRqwM0y_ed8a-2Dq4-DFFhA5gAO2ijNNMAu993Fz0NLh77l_HN7fCq37uJc6aIik0pBJUKJ0BJCoopoIwzoJgWpD0FyAIXlEBJuIEsS4qMc1HKJDO05FmOWRcdrbwz797mEBpd2ZDDdGpqcPOgCWeYKYnb1bro4A86cXNft79rKaoEJoouhccrKvcuBA-lnnlbGb_QBOtlWd2W1V9lW3b_2zjPKih-yZ-ULXC6At7tFBb_m_To_OFHGa8mbGjg43eiDaxlwhKhn8dDfc-FZNfXQg_YJw-mjnE</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Brockmann, Kathrin</creator><creator>Schulte, Claudia</creator><creator>Hauser, Ann-Kathrin</creator><creator>Lichtner, Peter</creator><creator>Huber, Heiko</creator><creator>Maetzler, Walter</creator><creator>Berg, Daniela</creator><creator>Gasser, Thomas</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>SNCA: Major genetic modifier of age at onset of Parkinson's disease</title><author>Brockmann, Kathrin ; Schulte, Claudia ; Hauser, Ann-Kathrin ; Lichtner, Peter ; Huber, Heiko ; Maetzler, Walter ; Berg, Daniela ; Gasser, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3919-af5526907e218e939e2343e202d1e205e6d0d21ef14aebb7db445f67ba2f4bc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>age at onset</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>alpha-Synuclein - genetics</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Genetic Association Studies</topic><topic>genetics</topic><topic>Humans</topic><topic>Linear Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Movement disorders</topic><topic>Mutation - genetics</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson's disease</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>SNCA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brockmann, Kathrin</creatorcontrib><creatorcontrib>Schulte, Claudia</creatorcontrib><creatorcontrib>Hauser, Ann-Kathrin</creatorcontrib><creatorcontrib>Lichtner, Peter</creatorcontrib><creatorcontrib>Huber, Heiko</creatorcontrib><creatorcontrib>Maetzler, Walter</creatorcontrib><creatorcontrib>Berg, Daniela</creatorcontrib><creatorcontrib>Gasser, Thomas</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brockmann, Kathrin</au><au>Schulte, Claudia</au><au>Hauser, Ann-Kathrin</au><au>Lichtner, Peter</au><au>Huber, Heiko</au><au>Maetzler, Walter</au><au>Berg, Daniela</au><au>Gasser, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SNCA: Major genetic modifier of age at onset of Parkinson's disease</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov Disord</addtitle><date>2013-08</date><risdate>2013</risdate><volume>28</volume><issue>9</issue><spage>1217</spage><epage>1221</epage><pages>1217-1221</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><coden>MOVDEA</coden><abstract>ABSTRACT Age at onset serves as a predictor of progression and mortality in sporadic Parkinson's disease (PD). Therefore, the identification of genetic modifiers for age at onset might lead to a better understanding of disease pathogenesis. We performed multivariate linear regression analysis in 1396 sporadic PD patients assessing 21 single‐nucleotide polymorphisms (SNPs) that have been previously suggested to be associated with sporadic PD. Moreover, a cumulative risk score was assigned to each patient and correlated with age at onset. We identified the rs356219 risk allele in the SNCA gene as significantly contributing to earlier age at onset. Neither one of the other 21 SNPs tested in this analysis nor the cumulative number of risk alleles showed a significant impact on PD onset. Because sequence variants in the SNCA gene are not only associated with autosomal dominantly inherited PD and increased susceptibility for sporadic PD but also have been found to modify the phenotype such as age at onset in both sporadic and various monogenic forms of PD, this gene serves as an outstanding target for further research on PD pathogenesis, which in return might provide potential therapeutic options. © 2013 Movement Disorder Society</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23674386</pmid><doi>10.1002/mds.25469</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2013-08, Vol.28 (9), p.1217-1221
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_miscellaneous_1430396074
source MEDLINE; Wiley Online Library All Journals
subjects Adult
age at onset
Age of Onset
Aged
alpha-Synuclein - genetics
Cohort Studies
Female
Genetic Association Studies
genetics
Humans
Linear Models
Male
Middle Aged
Movement disorders
Mutation - genetics
Parkinson Disease - genetics
Parkinson Disease - physiopathology
Parkinson's disease
Polymorphism, Single Nucleotide - genetics
SNCA
title SNCA: Major genetic modifier of age at onset of Parkinson's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T06%3A39%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SNCA:%20Major%20genetic%20modifier%20of%20age%20at%20onset%20of%20Parkinson's%20disease&rft.jtitle=Movement%20disorders&rft.au=Brockmann,%20Kathrin&rft.date=2013-08&rft.volume=28&rft.issue=9&rft.spage=1217&rft.epage=1221&rft.pages=1217-1221&rft.issn=0885-3185&rft.eissn=1531-8257&rft.coden=MOVDEA&rft_id=info:doi/10.1002/mds.25469&rft_dat=%3Cproquest_cross%3E3061320421%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1429501920&rft_id=info:pmid/23674386&rfr_iscdi=true